Sonophoresis

Last updated
An Aloka SSD 3500 ultrasound machine ALOKA SSD-3500SV.jpg
An Aloka SSD 3500 ultrasound machine

Sonophoresis also known as phonophoresis, is a method that utilizes ultrasound to enhance the delivery of topical medications through the stratum corneum, to the epidermis and dermis. Sonophoresis allows for the enhancement of the permeability of the skin along with other modalities, such as iontophoresis, to deliver drugs with lesser side effects. Currently, sonophoresis is used widely in transdermal drug delivery, but has potential applications in other sectors of drug delivery, such as the delivery of drugs to the eye and brain.

Contents

Historical advancements

Sonophoresis, also known as phonophoresis, was dated back all the way to the 1950s in its first mention in a published report. [1] This report showcased that a hydrocodone injection yielded better outcomes for bursitis when combined with an ultrasound massage. [2] Following this, a series of publications from several investigators showed the increased therapeutic effect when combining ultrasound with hydrocortisone injections for various other disease states, further demonstrating the novelty of sonophoresis. [2] However, while some researchers provided evidence that ultrasound had a positive effect on the transdermal permeation of drugs, others contradicted this information by displaying research that showed no quantitative effect using ultrasound. [2] These early studies mainly investigated the combination of therapeutics with high-frequency sonophoresis (HFS), which can be categorized into frequencies greater than 0.7 MHz. [1] High frequency sonophoresis usually includes a range between 0.7 – 16 MHz. [1] Studies evolved and HFS was continually studied for four decades until a greater understanding of a mechanism of action, cavitation, was discovered. [1] Cavitational effects are inversely proportional to the frequency of the ultrasound applied, which led to further studies of low-frequency sonophoresis (LFS) for use in transdermal drug delivery due to studies showing greater efficacy in enhancing skin permeability in comparison to HFS. [1] Low-frequency sonophoresis usually includes a range between 20 and 100 kHz. [1] For this reason, currently HFS focuses on topical applications for penetration through the stratum corneum, whereas LFS focuses on transdermal drug delivery applications.

Background

Ultrasonic sonicators generate ultrasound waves, which is a longitudinal compression wave, by converting electrical energy into mechanical energy by deformation of piezoelectric crystals in response to an electric field. [1] [3] The frequency of the waves generated by this method can range from 20 kHz up to 3 MHz. [3] The ultrasound waves generated from this device allow for penetration through biological tissue by molecular oscillation of the biological tissue they travel through. [1] [3] The amplitude of the wave can be modified by manipulating the displacement of the ultrasound horn for each half cycle as they are proportional.

The primary purpose of phonophoresis is to assist in transdermal drug delivery, usually with the help of a coupling agent or medium. Transdermal drug delivery sometimes does not permeate the skin to reach a targeted area within the body because of the stratum corneum layer of the skin, a layer that prevents foreign substances from penetrating the body. [4] [5] [6] Transdermal drug delivery is patient-compliance, [7] usually avoids digestive system degradation, [8] and has the ability to use drugs with short half-lives. [9]

Mechanisms of action

The layers of the epidermis - the stratum corneum layer can be seen at the top 502 Layers of epidermis.jpg
The layers of the epidermis – the stratum corneum layer can be seen at the top

While increased skin permeability is seen through sonophoresis, the precise mechanisms to describe sonophoresis are yet to be fully discovered. However, there are several important mechanisms that have been identified that contribute to the phenomenon of sonophoresis.

Cavitation

Cavitation is generally determined to be the dominant mechanism that drives sonophoresis. It can be described as the distortion, expansion, and contraction of gas bubbles in a liquid medium. [10] The frequency of the ultrasound waves helps determine the bubble parameters, such as size and shape. There exist two types of cavitation, stable and transient. Stable cavitation is when cavitation bubbles persist over many acoustic pressure cycles without collapsing. On the other hand, transient cavitation is where these cavitation bubbles uncontrollably and rapidly grow and decay over many acoustic pressure cycles. [1] However, while cavitation is considered the primary mechanism for sonophoresis, the gas bubbles that contribute to cavitation are generated by a process termed rectified diffusion. [1]

Rectified diffusion

Rectified diffusion is the process where cavitation bubbles experience growth. [1] The growth of these bubbles occurs by encountering a negative pressure half cycle, expanding the gas inside the bubble. Similarly, the gas bubble will dramatically decay in size when encountering the other positive half of the pressure cycle. [1] There are further factors that manipulate the oscillation of the bubbles’ size, such as temperature and composition of the gas and liquid phases. Depending on the dramatization of the oscillation from previously mentioned factors, stable or transient cavitation occurs. A rapid process will lead to transient cavitation bubbles, whereas a slower process will lead to stable cavitation bubbles. [1]

Thermal effects

An important consideration when transferring energy to a patient would be the thermal energy generated from heating of the biological tissue due to energy losses from the ultrasound waves. It has been shown that increases in temperature can increase skin permeability through several factors. [1] Two factors are increased kinetic energy and diffusivity of drugs, which allow for compounds to pass through the stratum corneum. Moreover, hair follicles and sweat glands are dilated, allowing for more points of entry for compounds. The enhanced circulation of blood that comes as a result of increased temperature from ultrasound parameters also allows for better diffusion of compounds. [1] While the intensity and duty cycle of the ultrasound are directly proportional to the corresponding thermal effects, surprisingly thermal effects are not a considerable mechanism for HFS in ranges from 1 – 2 degrees Celsius. [1] However, once larger temperature changes are observed, such as an excess of 10 degrees Celsius, permeant transport was increased. [1] When it comes to LFS, thermal effects are an important consideration on the side of safety. Thermal effects need to be minimized at higher amplitudes, as burns and necrosis of tissues can occur due to exposure to high, sustained temperatures. [1] A simple solution to counteract sustained exposure to high temperatures is to periodically replace the coupling agent every so often. [11]

Synergistic combination with other enhancement techniques

While sonophoresis alone is able to increase the permeability of skin by several factors depending on the procedure and the drug being delivered, a synergistic combination of sonophoresis with other enhancers, such as iontophoresis and electroporation, has shown greater enhancement as well as increased safety in reduction of individual enhancer parameters. [2]

Iontophoresis

Iontophoresis is similar to sonophoresis as it is a method for transdermal drug delivery but does so by applying a voltage gradient across the skin. Since there are differences in pathways between iontophoresis and sonophoresis, a combination of these two methods allows for greater enhancement. [2] For example, Le et al. displayed, for the case of heparin, that a combination of iontophoresis and sonophoresis resulted in a 56-fold enhancement of heparin flux in comparison to sonophoresis having a 3-fold enhancement and iontophoresis having a 15-fold enhancement. [12]

Electroporation

Electroporation allows the cell membrane to open up after applying an electric field. By applying short, high voltage pulses to the stratum corneum, the lipid structure will become disorganized and allow enhancement of drug delivery. [3] There are currently very few reports of the combination of these modalities being used together. However, in these reports, there is mention that the transdermal enhancement created by the combination was greater than the sum of the individual enhancers, suggesting that electroporation and sonophoresis work together synergistically. [3]

Treatment

Treatment methods

Phonophoresis can be performed using two main methods: The first is simultaneous treatment, where the drug can be applied at the same time as the ultrasound. The second method is pretreatment, where the ultrasound is used briefly before drug delivery. [8] [9] [13] [7] This is to ensure that the skin is permeable prior to the drug being applied.

When using an ultrasound, cavities will develop due to the pressure change. Stable cavitation describes the repetitive oscillations of a cavity bubble, while inertial cavitation describes the collapse of a cavity bubble. [8] If the developed cavities fall apart, the effect on the stratum corneum lipids will increase the permeability of the skin. [9] [6] These areas of increased permeability are often called localized transport regions, where there is lower electrical resistivity. [14] One potential method is to use cavitation seed at the surface of the skin. [15] Another potential method is to use ultrasound-responsive liquid-core nuclei (URLN). [6]

Frequency

Low-frequency ultrasound is seen as the optimal level of ultrasound frequency. This is typically characterized as 20 to 100 kHz (sometimes 18 to 100 kHz). [7] Low frequency makes cavitation more likely. For reference, high frequency ultrasound is typically in the range of 1 to 3 MHz. [8]

Coupling agents

The drug should be able to work together with the coupling agent. [9] In a 2019 study, they used the drug diclofenac in coordination with thiocolchioside gel to treat patients who suffer from acute lower back pain. [16] An application of a drug serving as a coupling agent is the use of piroxicam gel mixtures and dexamethasone sodium phosphate gel mixtures to treat patients who suffer from carpal tunnel syndrome. [17]

Applications

Physical conditions

Various conditions that can be addressed include cervical spine pain, [18] acute lower back pain, [16] carpal tunnel syndrome, [17] muscle injury, [19] rheumatoid arthritis, [20] and venous thrombosis. [5] Examples of drugs that have been used with sonophoresis include hydrocortisone, mannitol, dexamethasone, and lidocaine. [9]

Several products have been marketed to use phonophoresis for transdermal drug delivery. [9]

Other uses

A potential future application of phonophoresis is to use it with vaccines, as phonophoresis is considered a less painful alternative to needles. [14] [9] [7] [4] Another potential use is in cancer therapeutics; one such application that has been explored is the delivery of cisplatin for patients who have cervical cancer. [21] Genetic skin diseases and wound healing may be assisted by phonophoresis. [9]

Future potential and other applications

Regarding high frequency sonophoresis (HFS), the future potential is very similar to its usage in the past. Many of the treatments involving HFS are topical and regional. [1] Commonly used drugs in these topical applications include anti-inflammatory medications such as cortisol and dexamethasone. However, there has been a notable shift towards using non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and ketoprofen. [1] NSAIDs commonly cause gastrointestinal side effects such as nausea and heartburn, which can all be bypassed by delivering NSAIDs using sonophoresis. [1] With its credible safety and useful ability in penetrating the stratum corneum, HFS remains an incredibly versatile option for delivering drugs topically. Low frequency sonophoresis (LFS), on the other hand, has a variety of applications that can be built upon in the future. Since LFS is not restricted by its ability to deliver molecules of varying sizes, drugs such as proteins, nanoparticles, and vaccines are all possible targets. [22]

Ocular delivery

In previous literature, it has been demonstrated that ocular delivery of drugs can be achieved with high efficacy and minimal invasion. With 20 kHz ultrasound waves at an average temporal intensity of 2 W/cm^2applied every second, the permeability of drugs with varying lipophilicity were investigated, such as atenolol and carteolol, increased by 2.6 and 2.8-fold respectively. [3]

Topical gene therapy

Topical gene therapy is another area for investigation in combination with sonophoresis. Since there exists a need to enhance gene transfer into cells, sonophoresis has the ability to achieve higher transfection rate through acoustic cavitation. [23] Additionally, there is the advancement of using microbubbles with a contrast agent to diagnostically image the brain, as LFS and cavitation allows for disruption of the blood brain barrier. [24] Gene therapy using ultrasound and microbubbles is also being investigated for ocular disease. [25] In cardiovascular disease, for example, the efficiency of gene therapy can be improved by ultrasound targeted microbubble destruction where a gene-loaded microbubble can be burst to release its contents. [26]

Challenges

Research being done on sonophoresis is poorly standardized. For example, the emission of ultrasound waves further away from the source results in a greater beam area, which drastically changes the ultrasound energy at the targeted area. [3] More challenges surround the cost of the actual ultrasound devices used in sonophoresis in more clinical settings. There still yet exists a low-cost device with high efficacy. [27] Additionally the precise mechanisms as to how sonophoresis works is currently yet to be discovered. Further research into the mechanisms, and the dominant mechanisms, can allow for better optimization of sonophoresis parameters, which will increase the efficacy of treatments.

Areas of sonophoretic research include the application of various drugs, dual-frequency sonophoresis, combined transdermal drug delivery techniques, and the use of nanoparticles to carry drugs. [28]

At an optimal frequency, phonophoresis will be painless and have minimal to no risk. The heat that is emitted from ultrasound use can also be damaging to the surface of the skin, [13] and cavitation can potentially lead to tissue damage. [13] Nanoparticle toxicity is another potential risk. [13]

Related Research Articles

<span class="mw-page-title-main">Epidermis</span> Outermost of the three layers that make up the skin

The epidermis is the outermost of the three layers that comprise the skin, the inner layers being the dermis and hypodermis. The epidermis layer provides a barrier to infection from environmental pathogens and regulates the amount of water released from the body into the atmosphere through transepidermal water loss.

Iontophoresis is a process of transdermal drug delivery by use of a voltage gradient on the skin. Molecules are transported across the stratum corneum by electrophoresis and electroosmosis and the electric field can also increase the permeability of the skin. These phenomena, directly and indirectly, constitute active transport of matter due to an applied electric current. The transport is measured in units of chemical flux, commonly μmol/(cm2×hour). Iontophoresis has experimental, therapeutic and diagnostic applications.

<span class="mw-page-title-main">Contrast-enhanced ultrasound</span> Medical imaging technique

Contrast-enhanced ultrasound (CEUS) is the application of ultrasound contrast medium to traditional medical sonography. Ultrasound contrast agents rely on the different ways in which sound waves are reflected from interfaces between substances. This may be the surface of a small air bubble or a more complex structure. Commercially available contrast media are gas-filled microbubbles that are administered intravenously to the systemic circulation. Microbubbles have a high degree of echogenicity. There is a great difference in echogenicity between the gas in the microbubbles and the soft tissue surroundings of the body. Thus, ultrasonic imaging using microbubble contrast agents enhances the ultrasound backscatter, (reflection) of the ultrasound waves, to produce a sonogram with increased contrast due to the high echogenicity difference. Contrast-enhanced ultrasound can be used to image blood perfusion in organs, measure blood flow rate in the heart and other organs, and for other applications.

<span class="mw-page-title-main">Human skin</span> Organ covering the outside of the human body

The human skin is the outer covering of the body and is the largest organ of the integumentary system. The skin has up to seven layers of ectodermal tissue guarding muscles, bones, ligaments and internal organs. Human skin is similar to most of the other mammals' skin, and it is very similar to pig skin. Though nearly all human skin is covered with hair follicles, it can appear hairless. There are two general types of skin: hairy and glabrous skin (hairless). The adjective cutaneous literally means "of the skin".

<span class="mw-page-title-main">Transdermal</span> Method of drug administration

Transdermal is a route of administration wherein active ingredients are delivered across the skin for systemic distribution. Examples include transdermal patches used for medicine delivery. The drug is administered in the form of a patch or ointment that delivers the drug into the circulation for systemic effect.

Therapeutic ultrasound refers generally to any type of ultrasonic procedure that uses ultrasound for therapeutic benefit. Physiotherapeutic ultrasound was introduced into clinical practice in the 1950s, with lithotripsy introduced in the 1980s. Others are at various stages in transitioning from research to clinical use: HIFU, targeted ultrasound drug delivery, trans-dermal ultrasound drug delivery, ultrasound hemostasis, cancer therapy, and ultrasound assisted thrombolysis It may use focused ultrasound or unfocused ultrasound.

<span class="mw-page-title-main">Sonoporation</span> Technique in molecular biology

Sonoporation, or cellular sonication, is the use of sound in the ultrasonic range for increasing the permeability of the cell plasma membrane. This technique is usually used in molecular biology and non-viral gene therapy in order to allow uptake of large molecules such as DNA into the cell, in a cell disruption process called transfection or transformation. Sonoporation employs the acoustic cavitation of microbubbles to enhance delivery of these large molecules. The exact mechanism of sonoporation-mediated membrane translocation remains unclear, with a few different hypotheses currently being explored.

Microbubbles are bubbles smaller than one hundredth of a millimetre in diameter, but larger than one micrometre. They have widespread application in industry, medicine, life science, and food technology. The composition of the bubble shell and filling material determine important design features such as buoyancy, crush strength, thermal conductivity, and acoustic properties.

<span class="mw-page-title-main">Sonodynamic therapy</span>

Sonodynamic therapy (SDT) is a noninvasive treatment, often used for tumor irradiation, that utilizes a sonosensitizer and the deep penetration of ultrasound to treat lesions of varying depths by reducing target cell number and preventing future tumor growth. Many existing cancer treatment strategies cause systemic toxicity or cannot penetrate tissue deep enough to reach the entire tumor; however, emerging ultrasound stimulated therapies could offer an alternative to these treatments with their increased efficiency, greater penetration depth, and reduced side effects. Sonodynamic therapy could be used to treat cancers and other diseases, such as atherosclerosis, and diminish the risk associated with other treatment strategies since it induces cytotoxic effects only when externally stimulated by ultrasound and only at the cancerous region, as opposed to the systemic administration of chemotherapy drugs.

<span class="mw-page-title-main">Joseph Kost</span> Chemical engineering researcher

Joseph Kost is an Israeli academic, currently holder of The Abraham and Bessie Zacks Chair in Biomedical Engineering and the past Dean of the Faculty of Engineering Sciences at the Ben-Gurion University of the Negev.

<span class="mw-page-title-main">Microneedle drug delivery</span> System for vaccination

Microneedles or Microneedle patches or Microarray patches are micron-scaled medical devices used to administer vaccines, drugs, and other therapeutic agents. While microneedles were initially explored for transdermal drug delivery applications, their use has been extended for the intraocular, vaginal, transungual, cardiac, vascular, gastrointestinal, and intracochlear delivery of drugs. Microneedles are constructed through various methods, usually involving photolithographic processes or micromolding. These methods involve etching microscopic structure into resin or silicon in order to cast microneedles. Microneedles are made from a variety of material ranging from silicon, titanium, stainless steel, and polymers. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. The microneedles range in size, shape, and function but are all used as an alternative to other delivery methods like the conventional hypodermic needle or other injection apparatus.

<span class="mw-page-title-main">Topical cream formulation</span>

Topical cream formulation is an emulsion semisolid dosage form that is used for skin external application. Most of the topical cream formulations contain more than 20 per cent of water and volatiles and/or less than 50 per cent of hydrocarbons, waxes, or polyethylene glycols as the vehicle for external skin application. In a topical cream formulation, ingredients are dissolved or dispersed in either a water-in-oil (W/O) emulsion or an oil-in-water (O/W) emulsion. The topical cream formulation has a higher content of oily substance than gel, but a lower content of oily ingredient than ointment. Therefore, the viscosity of topical cream formulation lies between gel and ointment. The pharmacological effect of the topical cream formulation is confined to the skin surface or within the skin. Topical cream formulation penetrates through the skin by transcellular route, intercellular route, or trans-appendageal route. Topical cream formulation is used for a wide range of diseases and conditions, including atopic dermatitis (eczema), psoriasis, skin infection, acne, and wart. Excipients found in a topical cream formulation include thickeners, emulsifying agents, preservatives, antioxidants, and buffer agents. Steps required to manufacture a topical cream formulation include excipient dissolution, phase mixing, introduction of active substances, and homogenization of the product mixture.

Topical drug delivery (TDD) is a route of drug administration that allows the topical formulation to be delivered across the skin upon application, hence producing a localized effect to treat skin disorders like eczema. The formulation of topical drugs can be classified into corticosteroids, antibiotics, antiseptics, and anti-fungal. The mechanism of topical delivery includes the diffusion and metabolism of drugs in the skin. Historically, topical route was the first route of medication used to deliver drugs in humans in ancient Egyptian and Babylonian in 3000 BCE. In these ancient cities, topical medications like ointments and potions were used on the skin. The delivery of topical drugs needs to pass through multiple skin layers and undergo pharmacokinetics, hence factor like dermal diseases minimize the bioavailability of the topical drugs. The wide use of topical drugs leads to the advancement in topical drug delivery. These advancements are used to enhance the delivery of topical medications to the skin by using chemical and physical agents. For chemical agents, carriers like liposomes and nanotechnologies are used to enhance the absorption of topical drugs. On the other hand, physical agents, like micro-needles is other approach for enhancement ofabsorption. Besides using carriers, other factors such as pH, lipophilicity, and drug molecule size govern the effectiveness of topical formulation.

<span class="mw-page-title-main">Focused ultrasound for intracranial drug delivery</span> Medical technique

Focused ultrasound for intracrainial drug delivery is a non-invasive technique that uses high-frequency sound waves to disrupt tight junctions in the blood–brain barrier (BBB), allowing for increased passage of therapeutics into the brain. The BBB normally blocks nearly 98% of drugs from accessing the central nervous system, so FUS has the potential to address a major challenge in intracranial drug delivery by providing targeted and reversible BBB disruption. Using FUS to enhance drug delivery to the brain could significantly improve patient outcomes for a variety of diseases including Alzheimer's disease, Parkinson's disease, and brain cancer.

Ozone micro/nano-bubble technology overcomes the limitation of ozone oxidation and mass transfer of ozone and its utilization. It improves the oxidation efficiency of ozone. Ozone micro/nano-bubble technology improves the disinfectant capacity of ozone.

Penetration enhancers are chemical compounds that can facilitate the penetration of active pharmaceutical ingredients (API) into or through the poorly permeable biological membranes. These compounds are used in some pharmaceutical formulations to enhance the penetration of APIs in transdermal drug delivery and transmucosal drug delivery. They typically penetrate into the biological membranes and reversibly decrease their barrier properties.

Ultrasound-triggered drug delivery using stimuli-responsive hydrogels refers to the process of using ultrasound energy for inducing drug release from hydrogels that are sensitive to acoustic stimuli. This method of approach is one of many stimuli-responsive drug delivery-based systems that has gained traction in recent years due to its demonstration of localization and specificity of disease treatment. Although recent developments in this field highlight its potential in treating certain diseases such as COVID-19, there remain many major challenges that need to be addressed and overcome before more related biomedical applications are clinically translated into standard of care.

Focused-ultrasound-mediated diagnostics or FUS-mediated diagnostics are an area of clinical diagnostic tools that use ultrasound to detect diseases and cancers. Although ultrasound has been used for imaging in various settings, focused-ultrasound refers to the detection of specific cells and biomarkers under flow combining ultrasound with lasers, microbubbles, and imaging techniques. Current diagnostic techniques for detecting tumors and diseases using biopsies often include invasive procedures and require improved accuracy, especially in cases such as glioblastoma and melanoma. The field of FUS-mediated diagnostics targeting cells and biomarkers is being investigated for overcoming these limitations.

<span class="mw-page-title-main">Invasomes</span> Transdermal drug delivery method

An invasome is a type of artificial vesicle nanocarrier that transport substances through the skin, the most superficial biological barrier. Vesicles are small particles surrounded by a lipid layer that can carry substances into and out of the cell. Artificial vesicles can be engineered to deliver drugs within the cell, with specific applications within transdermal drug delivery. However, the skin proves to be a barrier to effective penetration and delivery of drug therapies. Thus, invasomes are a new generation of vesicle with added structural components to assist with skin penetration.

Laser-assisted drug delivery (LADD) is a drug delivery technique commonly used in the dermatology field that involves lasers. As skin acts as a protective barrier to the environment, the absorption of topical products through the epidermis is limited; thus, different drug delivery modalities have been employed to improve the efficacy of these treatments. The use of lasers in LADD has been shown to enhance the penetration of drugs transdermal, leading to a higher absorption rate, limited systemic effects, and reduced duration of treatment. Although this technique has evolved in the past decade due to its efficacy through scientific research and clinical practice, there remain some limitations regarding the safety aspect that needs to be taken into consideration.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Polat, Baris E.; Hart, Douglas; Langer, Robert; Blankschtein, Daniel (June 2011). "Ultrasound-mediated transdermal drug delivery: Mechanisms, scope, and emerging trends". Journal of Controlled Release. 152 (3): 330–348. doi:10.1016/j.jconrel.2011.01.006. hdl:1721.1/99225. PMC   3436072 . PMID   21238514.
  2. 1 2 3 4 5 Mitragotri, Samir; Kost, Joseph (March 2004). "Low-frequency sonophoresis". Advanced Drug Delivery Reviews. 56 (5): 589–601. doi:10.1016/j.addr.2003.10.024. PMID   15019748.
  3. 1 2 3 4 5 6 7 Rao, Rekha; Nanda, Sanju (2010-01-08). "Sonophoresis: recent advancements and future trends". Journal of Pharmacy and Pharmacology. 61 (6): 689–705. doi: 10.1211/jpp.61.06.0001 . ISSN   0022-3573. PMID   19505359. S2CID   4247361.
  4. 1 2 Yang Y, Xia L, Ning X, Hu T, Xu C, Liu W (December 2021). "Enhanced Drug Permeation into Human Keloid Tissues by Sonophoresis-Assisted Microneedling". SLAS Technology. 26 (6): 660–666. doi: 10.1177/24726303211024568 . PMID   34219535. S2CID   235732832.
  5. 1 2 Zhai H, Zhang C, Ou H, Chen M (August 2021). "Transdermal delivery of heparin using low-frequency sonophoresis in combination with sponge spicules for venous thrombosis treatment". Biomaterials Science. 9 (16): 5612–5625. doi:10.1039/D1BM00703C. PMID   34254062. S2CID   235809367.
  6. 1 2 3 Park D, Won J, Lee G, Lee Y, Kim CW, Seo J (March 2022). "Sonophoresis with ultrasound-responsive liquid-core nuclei for transdermal drug delivery". Skin Research and Technology. 28 (2): 291–298. doi: 10.1111/srt.13129 . PMC   9907662 . PMID   35034386. S2CID   247599798.
  7. 1 2 3 4 Lavon I, Kost J (August 2004). "Ultrasound and transdermal drug delivery". Drug Discovery Today. 9 (15): 670–676. doi:10.1016/S1359-6446(04)03170-8. PMID   15279850.
  8. 1 2 3 4 Machet L, Boucaud A (August 2002). "Phonophoresis: efficiency, mechanisms and skin tolerance". International Journal of Pharmaceutics. 243 (1–2): 1–15. doi:10.1016/S0378-5173(02)00299-5. PMID   12176291.
  9. 1 2 3 4 5 6 7 8 Rao R, Nanda S (June 2009). "Sonophoresis: recent advancements and future trends". The Journal of Pharmacy and Pharmacology. 61 (6): 689–705. doi: 10.1211/jpp.61.06.0001 . PMID   19505359. S2CID   4247361.
  10. ↑ Park, Donghee; Park, Hyunjin; Seo, Jongbum; Lee, Seunghun (January 2014). "Sonophoresis in transdermal drug deliverys". Ultrasonics. 54 (1): 56–65. doi:10.1016/j.ultras.2013.07.007. PMID   23899825.
  11. ↑ Tang, Hua; Wang, Chiao Chun Joanne; Blankschtein, Daniel; Langer, Robert (2002). "An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport". Pharmaceutical Research. 19 (8): 1160–1169. doi:10.1023/A:1019898109793. PMID   12240942. S2CID   7650314.
  12. ↑ Le, Long (2000). "Combined effect of low-frequency ultrasound and iontophoresis: Applications for transdermal heparin delivery". Pharmaceutical Research. 17 (9): 1151–1154. doi:10.1023/A:1026426317413. PMID   11087051. S2CID   42575492.
  13. 1 2 3 4 Seah BC, Teo BM (2018). "Recent advances in ultrasound-based transdermal drug delivery". International Journal of Nanomedicine. 13: 7749–7763. doi: 10.2147/IJN.S174759 . PMC   6251463 . PMID   30538456.
  14. 1 2 Ogura M, Paliwal S, Mitragotri S (June 2008). "Low-frequency sonophoresis: current status and future prospects". Advanced Drug Delivery Reviews. 60 (10): 1218–1223. doi:10.1016/j.addr.2008.03.006. PMID   18450318.
  15. ↑ Park D, Won J, Shin UC, Park H, Song G, Jang J, Park H, Kim CW, Seo J (April 2019). "Transdermal Drug Delivery using a Specialized Cavitation Seed for Ultrasound". IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control. 66 (6): 1057–1064. doi:10.1109/TUFFC.2019.2907702. PMID   30946663. S2CID   96432587.
  16. 1 2 Altan L, Kasapoğlu Aksoy M, Kösegil Öztürk E (January 2019). "Efficacy of diclofenac & thiocolchioside gel phonophoresis comparison with ultrasound therapy on acute low back pain; a prospective, double-blind, randomized clinical study". Ultrasonics. 91: 201–205. doi:10.1016/j.ultras.2018.08.008. PMID   30139568. S2CID   52076491.
  17. 1 2 Boonhong J, Thienkul W (January 2020). "Effectiveness of Phonophoresis Treatment in Carpal Tunnel Syndrome: A Randomized Double-blind, Controlled Trial". PM&R. 12 (1): 8–15. doi:10.1002/pmrj.12171. PMID   31006972. S2CID   128352578.
  18. ↑ Aiyegbusi AI, Sanni HO, Akinbo SR (2019). "Intrasound Therapy: An Effective Alternative to Sodium Diclofenac Phonophoresis in the Management of Mechanical Chronic Cervical Spine Pain". Journal of Applied Sciences and Environmental Management. 23 (2): 371. doi: 10.4314/jasem.v23i2.26 . S2CID   86999653.
  19. ↑ Dos Santos Haupenthal DP, Zortea D, Zaccaron RP, de Bem Silveira G, Corrêa ME, Mendes C, de Roch Casagrande L, Duarte MB, Pinho RA, Feuser PE, Machado-de-Ávila RA, Silveira PC (May 2020). "Effects of phonophoresis with diclofenac linked gold nanoparticles in model of traumatic muscle injury". Materials Science & Engineering. C, Materials for Biological Applications. 110: 110681. doi:10.1016/j.msec.2020.110681. PMID   32204109. S2CID   212931024.
  20. ↑ Vaidya J, Shende P (June 2020). "Potential of Sonophoresis as a Skin Penetration Technique in the Treatment of Rheumatoid Arthritis with Transdermal Patch". AAPS PharmSciTech. 21 (5): 180. doi:10.1208/s12249-020-01725-w. PMID   32601758. S2CID   220261137.
  21. ↑ Ma S, Liu C, Li B, Zhang T, Jiang L, Wang R (2020). "Sonophoresis Enhanced Transdermal Delivery of Cisplatin in the Xenografted Tumor Model of Cervical Cancer". OncoTargets and Therapy. 13: 889–902. doi: 10.2147/OTT.S238126 . PMC   6996214 . PMID   32099393.
  22. ↑ Bjarnason, I.; Hayllar, J.; MacPherson, A. J.; Russell, A. S. (June 1993). "Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans". Gastroenterology. 104 (6): 1832–1847. doi: 10.1016/0016-5085(93)90667-2 . ISSN   0016-5085. PMID   8500743.
  23. ↑ Bao, Shiping; Thrall, Brian D.; Miller, Douglas L. (January 1997). "Transfection of a reporter plasmid into cultured cells by sonoporation in vitro". Ultrasound in Medicine & Biology. 23 (6): 953–959. doi:10.1016/S0301-5629(97)00025-2. PMID   9300999.
  24. ↑ Raymond, Scott B.; Treat, Lisa H.; Dewey, Jonathan D.; McDannold, Nathan J.; Hynynen, Kullervo; Bacskai, Brian J. (2008-05-14). Bush, Ashley I. (ed.). "Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models". PLOS ONE. 3 (5): e2175. Bibcode:2008PLoSO...3.2175R. doi: 10.1371/journal.pone.0002175 . ISSN   1932-6203. PMC   2364662 . PMID   18478109.
  25. ↑ Wan, C; Li, F; Li, H (October 2015). "Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)". Molecular Medicine Reports. 12 (4): 4803–14. doi:10.3892/mmr.2015.4054. PMC   4581786 . PMID   26151686.
  26. ↑ Chen, ZY; Lin, Y; Yang, F; Jiang, L; Ge, Sp (17 April 2013). "Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles". Cardiovascular Ultrasound. 11: 11. doi: 10.1186/1476-7120-11-11 . PMC   3653772 . PMID   23594865.
  27. ↑ Boucaud, Alain (October 2004). "Trends in the use of ultrasound-mediated transdermal drug delivery". Drug Discovery Today. 9 (19): 827–828. doi:10.1016/S1359-6446(04)03212-X. PMID   15381133.
  28. ↑ Seah, Brenden Cheong-Qi; Teo, Boon Mian (20 November 2018). "Recent advances in ultrasound-based transdermal drug delivery". International Journal of Nanomedicine. 13: 7749–7763. doi: 10.2147/IJN.S174759 . PMC   6251463 . PMID   30538456.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.